Biovet obtains the Alquernat Zycox patent

The intestinal optimizer normalizes the immune system of the gastrointestinal tract

On 4th May 2020, Biovet S.A. obtained the patent of Alquernat Zycox product in Spain. It is an intestinal optimizer based on pronutrients which reinforces the intestinal mucosa and normalizes the activity of the local immune system of the gastrointestinal tract.

Alquernat Zycox is part of the pronutrients line of Biovet S.A. which is composed of natural products made with plant extracts that contain pronutrients. These molecules are capable to improve animal physiology by increasing gene expression. Its use is an effective alternative to chemical additives and does not generate resistance and does not require withdrawal period.

Alquernat Zycox contains intestinal optimizer pronutrients which stimulate the local immune system of the intestine. The immune system is then capable of breaking the reproductive cycle of coccidia, so these parasites can’t penetrate other cells and damage the mucosa.

Alquernat Zycox is available in premix and oral solution format and it is intended for poultry, pig, ruminants and aquaculture. Its use has been proved in several in vitro and in vivo trials and has demonstrated to be an effective tool to improve production parameters and animal welfare.